Cargando…

Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy

BACKGROUND: Many malignant tumours have increased TSPO expression, which has been related to a poor prognosis. TSPO-PET tracers have not comprehensively been evaluated in peripherally located tumours. This study aimed to evaluate whether N,N-diethyl-2-(2-(4-([(18)F]fluoro)phenyl)-5,7-dimethylpyrazol...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuominen, Sanni, Keller, Thomas, Petruk, Nataliia, López-Picón, Francisco, Eichin, Dominik, Löyttyniemi, Eliisa, Verhassel, Alejandra, Rajander, Johan, Sandholm, Jouko, Tuomela, Johanna, Grönroos, Tove J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113193/
https://www.ncbi.nlm.nih.gov/pubmed/33340054
http://dx.doi.org/10.1007/s00259-020-05115-z
_version_ 1783690807545430016
author Tuominen, Sanni
Keller, Thomas
Petruk, Nataliia
López-Picón, Francisco
Eichin, Dominik
Löyttyniemi, Eliisa
Verhassel, Alejandra
Rajander, Johan
Sandholm, Jouko
Tuomela, Johanna
Grönroos, Tove J.
author_facet Tuominen, Sanni
Keller, Thomas
Petruk, Nataliia
López-Picón, Francisco
Eichin, Dominik
Löyttyniemi, Eliisa
Verhassel, Alejandra
Rajander, Johan
Sandholm, Jouko
Tuomela, Johanna
Grönroos, Tove J.
author_sort Tuominen, Sanni
collection PubMed
description BACKGROUND: Many malignant tumours have increased TSPO expression, which has been related to a poor prognosis. TSPO-PET tracers have not comprehensively been evaluated in peripherally located tumours. This study aimed to evaluate whether N,N-diethyl-2-(2-(4-([(18)F]fluoro)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide ([(18)F]F-DPA) can reflect radiotherapy (RT)-induced changes in TSPO activity in head and neck squamous cell carcinoma (HNSCC). METHODS: RT was used to induce inflammatory responses in HNSCC xenografts and cells. [(18)F]F-DPA uptake was measured in vivo in non-irradiated and irradiated tumours, followed by ex vivo biodistribution, autoradiography, and radiometabolite analysis. In vitro studies were performed in parental and TSPO-silenced (TSPO siRNA) cells. TSPO protein and mRNA expression, as well as tumour-associated macrophages (TAMs), were also assessed. RESULTS: In vivo imaging and ex vivo measurement revealed significantly higher [(18)F]F-DPA uptake in irradiated, compared to non-irradiated tumours. In vitro labelling studies with cells confirmed this finding, whereas no effect of RT on [(18)F]F-DPA uptake was detected in TSPO siRNA cells. Radiometabolite analysis showed that the amount of unchanged [(18)F]F-DPA in tumours was 95%, also after irradiation. PK11195 pre-treatment reduced the tumour-to-blood ratio of [(18)F]F-DPA by 73% in xenografts and by 88% in cells. TSPO protein and mRNA levels increased after RT, but were highly variable. The proportion of M1/M2 TAMs decreased after RT, whereas the proportion of monocytes and migratory monocytes/macrophages increased. CONCLUSIONS: [(18)F]F-DPA can detect changes in TSPO expression levels after RT in HNSCC, which does not seem to reflect inflammation. Further studies are however needed to clarify the physiological mechanisms regulated by TSPO after RT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-020-05115-z.
format Online
Article
Text
id pubmed-8113193
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81131932021-05-13 Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy Tuominen, Sanni Keller, Thomas Petruk, Nataliia López-Picón, Francisco Eichin, Dominik Löyttyniemi, Eliisa Verhassel, Alejandra Rajander, Johan Sandholm, Jouko Tuomela, Johanna Grönroos, Tove J. Eur J Nucl Med Mol Imaging Original Article BACKGROUND: Many malignant tumours have increased TSPO expression, which has been related to a poor prognosis. TSPO-PET tracers have not comprehensively been evaluated in peripherally located tumours. This study aimed to evaluate whether N,N-diethyl-2-(2-(4-([(18)F]fluoro)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide ([(18)F]F-DPA) can reflect radiotherapy (RT)-induced changes in TSPO activity in head and neck squamous cell carcinoma (HNSCC). METHODS: RT was used to induce inflammatory responses in HNSCC xenografts and cells. [(18)F]F-DPA uptake was measured in vivo in non-irradiated and irradiated tumours, followed by ex vivo biodistribution, autoradiography, and radiometabolite analysis. In vitro studies were performed in parental and TSPO-silenced (TSPO siRNA) cells. TSPO protein and mRNA expression, as well as tumour-associated macrophages (TAMs), were also assessed. RESULTS: In vivo imaging and ex vivo measurement revealed significantly higher [(18)F]F-DPA uptake in irradiated, compared to non-irradiated tumours. In vitro labelling studies with cells confirmed this finding, whereas no effect of RT on [(18)F]F-DPA uptake was detected in TSPO siRNA cells. Radiometabolite analysis showed that the amount of unchanged [(18)F]F-DPA in tumours was 95%, also after irradiation. PK11195 pre-treatment reduced the tumour-to-blood ratio of [(18)F]F-DPA by 73% in xenografts and by 88% in cells. TSPO protein and mRNA levels increased after RT, but were highly variable. The proportion of M1/M2 TAMs decreased after RT, whereas the proportion of monocytes and migratory monocytes/macrophages increased. CONCLUSIONS: [(18)F]F-DPA can detect changes in TSPO expression levels after RT in HNSCC, which does not seem to reflect inflammation. Further studies are however needed to clarify the physiological mechanisms regulated by TSPO after RT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-020-05115-z. Springer Berlin Heidelberg 2020-12-19 2021 /pmc/articles/PMC8113193/ /pubmed/33340054 http://dx.doi.org/10.1007/s00259-020-05115-z Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Tuominen, Sanni
Keller, Thomas
Petruk, Nataliia
López-Picón, Francisco
Eichin, Dominik
Löyttyniemi, Eliisa
Verhassel, Alejandra
Rajander, Johan
Sandholm, Jouko
Tuomela, Johanna
Grönroos, Tove J.
Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy
title Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy
title_full Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy
title_fullStr Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy
title_full_unstemmed Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy
title_short Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy
title_sort evaluation of [(18)f]f-dpa as a target for tspo in head and neck cancer under normal conditions and after radiotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113193/
https://www.ncbi.nlm.nih.gov/pubmed/33340054
http://dx.doi.org/10.1007/s00259-020-05115-z
work_keys_str_mv AT tuominensanni evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT kellerthomas evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT petruknataliia evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT lopezpiconfrancisco evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT eichindominik evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT loyttyniemieliisa evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT verhasselalejandra evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT rajanderjohan evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT sandholmjouko evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT tuomelajohanna evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy
AT gronroostovej evaluationof18ffdpaasatargetfortspoinheadandneckcancerundernormalconditionsandafterradiotherapy